Figueiro Mariana G, Bierman Andrew, Bullough John D, Rea Mark S
Lighting Research Center, Rensselaer Polytechnic Institute, Troy, New York 12180, USA.
Chronobiol Int. 2009 May;26(4):726-39. doi: 10.1080/07420520902927809.
Light treatment has been used as a non-pharmacological tool to help mitigate poor sleep quality frequently found in older people. In order to increase compliance to non-pharmacological light treatments, new, more efficacious light-delivery systems need to be developed. A prototype personal light-treatment device equipped with low brightness blue light-emitting diodes (LEDs) (peak wavelength near 470 nm) was tested for its effectiveness in suppressing nocturnal melatonin, a measure of circadian stimulation. Two levels of corneal irradiance were set to deliver two prescribed doses of circadian light exposure. Eleven older subjects, between 51 and 80 yrs of age who met the selection criteria, were exposed to a high and a low level of light for 90 min on separate nights from the personal light-treatment device. Blood and saliva samples were collected at prescribed times for subsequent melatonin assay. After 1 h of light exposure, the light-induced nocturnal melatonin suppression level was about 35% for the low-light level and about 60% for the high-light level. The higher level of blue light suppressed melatonin more quickly, to a greater extent over the course of the 90 min exposure period, and maintained suppression after 60 min. The constant exposure of the low-light level resulted in a decrease in nocturnal melatonin suppression for the last sampling time, whereas for the high-light level, suppression continued throughout the entire exposure period. The present study performed with healthy adults suggests that the tested personal light-treatment device might be a practical, comfortable, and effective way to deliver light treatment to those suffering from circadian sleep disorders; however, the acceptance and effectiveness of personal light-treatment devices by older people and by other segments of the population suffering from sleep disorders in a real-life situation need to be directly tested.
光疗法已被用作一种非药物工具,以帮助缓解老年人中常见的睡眠质量差问题。为了提高对非药物光疗法的依从性,需要开发新的、更有效的光输送系统。测试了一种配备低亮度蓝光发光二极管(LED)(峰值波长接近470纳米)的个人光疗设备在抑制夜间褪黑激素方面的有效性,褪黑激素是昼夜节律刺激的一种衡量指标。设置了两个角膜辐照度水平,以提供两种规定剂量的昼夜光照。11名年龄在51至80岁之间符合选择标准的老年受试者,在不同的夜晚从个人光疗设备接受90分钟的高光照和低光照。在规定时间采集血液和唾液样本,用于后续的褪黑激素测定。光照1小时后,低光照水平下光诱导的夜间褪黑激素抑制水平约为35%,高光照水平下约为60%。较高水平的蓝光在90分钟的暴露期内更迅速、更大程度地抑制了褪黑激素,并在60分钟后保持抑制状态。低光照水平的持续暴露导致最后采样时间的夜间褪黑激素抑制减少,而高光照水平下,抑制在整个暴露期持续存在。这项针对健康成年人的研究表明,测试的个人光疗设备可能是一种向患有昼夜节律性睡眠障碍的人提供光疗的实用、舒适且有效的方法;然而,在现实生活中,老年人和其他患有睡眠障碍的人群对个人光疗设备的接受度和有效性需要直接测试。